3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase NA
2
Phase 1
1
Status
Withdrawn
3
Terminated
3
Completed
2
Active not recruiting
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Breast Neoplasms
25
Neoplasms
19
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
15
Carcinoma, Hepatocellular
10
Urinary Bladder Neoplasms
8
Ovarian Neoplasms
8
Head and Neck Neoplasms
8
Pain
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Squamous Cell Carcinoma of Head and Neck
6
Neoplasm Metastasis
6
Lymphoma, Follicular
6
Leukemia
6
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Non-Muscle Invasive Bladder Neoplasms
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leiomyoma
4
Carcinoma
4
Urologic Neoplasms
3
Urogenital Neoplasms
3
Papillomavirus Infections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Withdrawn
×
Urologic Neoplasms
×
Clear all
NCT07313891
2026-03-17
BOOST
Relmada Therapeutics, Inc.
Phase 3
Withdrawn
NCT07342517
2026-03-17
RESCUE
Relmada Therapeutics, Inc.
Phase 3
Withdrawn
NCT02254915
2015-04-01
SHTC-EUROPE-1
Medical Enterprises Europe B.V.
Phase 3
Withdrawn